View in EDS

BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis.

Saved in:
Bibliographic Details
Title: BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis.
Authors: Verstovsek S; The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Al-Ali HK; Krukenberg Cancer Center, University Hospital, Halle, 33790, Germany., Mascarenhas J; Icahn School of Medicine at Mount Sinai, NY 10029, USA., Perkins A; Australian Centre for Blood Diseases, Monash University, Victoria, 3294, Australia., Vannucchi AM; University of Florence, Florence, 50121, Italy., Mohan SR; Vanderbilt University Medical Center, Nashville, TN 37232, USA., Scott BL; Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Woszczyk D; Hematology Department, University of Opole, Opole, 45-040, Poland., Koschmieder S; Department of Hematology, Oncology, Haemostaseology & Stem Cell Transplantation (Department of Medicine IV), Faculty of Medicine, RWTH University Aachen, Aachen, 52062, Germany., García-Delgado R; Virgen de la Victoria University Hospital, Málaga, 29010, Spain., László R; Josa András Teaching Hospital, Nyíregyháza, 4400, Hungary., McGreivy JS; Kartos Therapeutics, Inc., Redwood City, CA 94065, USA., Rothbaum WP; Kartos Therapeutics, Inc., Redwood City, CA 94065, USA., Kiladjian JJ; Saint-Louis Hospital & Université Paris Cité, Paris, 75010, France.
Source: Future oncology (London, England) [Future Oncol] 2022 Nov 23. Date of Electronic Publication: 2022 Nov 23.
Publication Type: Journal Article; Review
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36416118
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Verstovsek+S%22">Verstovsek S</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Al-Ali+HK%22">Al-Ali HK</searchLink>; Krukenberg Cancer Center, University Hospital, Halle, 33790, Germany.<br /><searchLink fieldCode="AU" term="%22Mascarenhas+J%22">Mascarenhas J</searchLink>; Icahn School of Medicine at Mount Sinai, NY 10029, USA.<br /><searchLink fieldCode="AU" term="%22Perkins+A%22">Perkins A</searchLink>; Australian Centre for Blood Diseases, Monash University, Victoria, 3294, Australia.<br /><searchLink fieldCode="AU" term="%22Vannucchi+AM%22">Vannucchi AM</searchLink>; University of Florence, Florence, 50121, Italy.<br /><searchLink fieldCode="AU" term="%22Mohan+SR%22">Mohan SR</searchLink>; Vanderbilt University Medical Center, Nashville, TN 37232, USA.<br /><searchLink fieldCode="AU" term="%22Scott+BL%22">Scott BL</searchLink>; Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.<br /><searchLink fieldCode="AU" term="%22Woszczyk+D%22">Woszczyk D</searchLink>; Hematology Department, University of Opole, Opole, 45-040, Poland.<br /><searchLink fieldCode="AU" term="%22Koschmieder+S%22">Koschmieder S</searchLink>; Department of Hematology, Oncology, Haemostaseology & Stem Cell Transplantation (Department of Medicine IV), Faculty of Medicine, RWTH University Aachen, Aachen, 52062, Germany.<br /><searchLink fieldCode="AU" term="%22García-Delgado+R%22">García-Delgado R</searchLink>; Virgen de la Victoria University Hospital, Málaga, 29010, Spain.<br /><searchLink fieldCode="AU" term="%22László+R%22">László R</searchLink>; Josa András Teaching Hospital, Nyíregyháza, 4400, Hungary.<br /><searchLink fieldCode="AU" term="%22McGreivy+JS%22">McGreivy JS</searchLink>; Kartos Therapeutics, Inc., Redwood City, CA 94065, USA.<br /><searchLink fieldCode="AU" term="%22Rothbaum+WP%22">Rothbaum WP</searchLink>; Kartos Therapeutics, Inc., Redwood City, CA 94065, USA.<br /><searchLink fieldCode="AU" term="%22Kiladjian+JJ%22">Kiladjian JJ</searchLink>; Saint-Louis Hospital & Université Paris Cité, Paris, 75010, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101256629%22">Future oncology (London, England)</searchLink> [Future Oncol] 2022 Nov 23. <i>Date of Electronic Publication: </i>2022 Nov 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101256629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8301 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214796694%22">14796694 </searchLink><i>NLM ISO Abbreviation: </i>Future Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36416118
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2217/fon-2022-0901
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Verstovsek S
      – PersonEntity:
          Name:
            NameFull: Al-Ali HK
      – PersonEntity:
          Name:
            NameFull: Mascarenhas J
      – PersonEntity:
          Name:
            NameFull: Perkins A
      – PersonEntity:
          Name:
            NameFull: Vannucchi AM
      – PersonEntity:
          Name:
            NameFull: Mohan SR
      – PersonEntity:
          Name:
            NameFull: Scott BL
      – PersonEntity:
          Name:
            NameFull: Woszczyk D
      – PersonEntity:
          Name:
            NameFull: Koschmieder S
      – PersonEntity:
          Name:
            NameFull: García-Delgado R
      – PersonEntity:
          Name:
            NameFull: László R
      – PersonEntity:
          Name:
            NameFull: McGreivy JS
      – PersonEntity:
          Name:
            NameFull: Rothbaum WP
      – PersonEntity:
          Name:
            NameFull: Kiladjian JJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 11
              Text: 2022 Nov 23
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8301
          Titles:
            – TitleFull: Future oncology (London, England)
              Type: main
ResultId 1